Literature DB >> 16321378

Puerarin protects rat pancreatic islets from damage by hydrogen peroxide.

Fu-Liang Xiong1, Xiao-Hui Sun, Lu Gan, Xiang-Liang Yang, Hui-Bi Xu.   

Abstract

The protective effect of puerarin, an isoflavone purified from Chinese herb radix of Pueraria lobata, on hydrogen peroxide (H(2)O(2))-induced rat pancreatic islets damage was investigated. Exposure of islets to 500 microM H(2)O(2) could cause a significant viability loss and an increase in apoptotic rate. Pretreatment of islets with puerarin for 48 h resulted in a reduction in viability loss and apoptotic rate. 100 microM puerarin significantly inhibited the apoptosis of islets induced by H(2)O(2). In addition, preincubation with puerarin could restore the H(2)O(2)-induced decrease in basal and glucose-stimulated insulin secretion in pancreatic islets. Puerarin was also found to inhibit the free radicals production induced by H(2)O(2) and to increase catalase and superoxide dismutase (SOD) activities in the isolated pancreatic islets. These results suggest that puerarin can protect islets against oxidative stress probably due to stimulating the activities of the antioxidant enzymes. Puerarin may be effective in preventing islet cells from the toxic action of reactive oxygen species in diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16321378     DOI: 10.1016/j.ejphar.2005.10.024

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  36 in total

Review 1.  Islet transplantation and antioxidant management: a comprehensive review.

Authors:  Seyed Sajad Mohseni Salehi Monfared; Bagher Larijani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

2.  Mitigating hypoxic stress on pancreatic islets via in situ oxygen generating biomaterial.

Authors:  Maria M Coronel; Ryan Geusz; Cherie L Stabler
Journal:  Biomaterials       Date:  2017-03-18       Impact factor: 12.479

3.  Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.

Authors:  Gang Chen; Shi-qi Pan; Cong Shen; Shi-fen Pan; Xiu-min Zhang; Qi-yang He
Journal:  Acta Pharmacol Sin       Date:  2014-03-10       Impact factor: 6.150

4.  Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway.

Authors:  E Youl; G Bardy; R Magous; G Cros; F Sejalon; A Virsolvy; S Richard; J F Quignard; R Gross; P Petit; D Bataille; C Oiry
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

5.  Puerarin Protects Pancreatic β-Cells in Obese Diabetic Mice via Activation of GLP-1R Signaling.

Authors:  Lei Yang; Dongdong Yao; Haiyuan Yang; Yingjie Wei; Yunru Peng; Yongfang Ding; Luan Shu
Journal:  Mol Endocrinol       Date:  2016-01-20

6.  Protective effect of puerarin on diabetic retinopathy in rats.

Authors:  Yan Teng; Hao Cui; Mingming Yang; Han Song; Qingsheng Zhang; Ying Su; Jianqiu Zheng
Journal:  Mol Biol Rep       Date:  2008-06-28       Impact factor: 2.316

Review 7.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

8.  Effects of puerarin on receptor for advanced glycation end products in nephridial tissue of streptozotocin-induced diabetic rats.

Authors:  Jian Guo Shen; Mei Fen Yao; Xiao Chan Chen; Yun Fei Feng; Yu Hong Ye; Zhong Hang Tong
Journal:  Mol Biol Rep       Date:  2009-01-06       Impact factor: 2.316

9.  Tissue distribution of puerarin and its conjugated metabolites in rats assessed by liquid chromatography-tandem mass spectrometry.

Authors:  Jeevan K Prasain; Ning Peng; Ray Moore; Alireza Arabshahi; Stephen Barnes; J Michael Wyss
Journal:  Phytomedicine       Date:  2008-11-21       Impact factor: 5.340

10.  Therapeutic effects of puerarin on polycystic ovary syndrome: A randomized trial in Chinese women.

Authors:  Wenjing Li; Hongbo Hu; Guofang Zou; Zhanzhong Ma; Jing Liu; Fanxiang Li
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.